The PCOS Stack: Inositol, Vitamin D, NAC, and Omega-3

7 min read ·
Bottom Line

For polycystic ovary syndrome, a stack of inositol, vitamin D, NAC, and omega-3 can support the insulin resistance and hormonal disturbances behind the condition, but none replaces lifestyle change or first-line medication. The evidence is strongest for myo-inositol, where randomized trials show improved insulin sensitivity, lower androgens, and more regular ovulation at 4 g/day — gentler than metformin — while vitamin D mainly helps women who are genuinely deficient and omega-3 acts on triglycerides and inflammation rather than ovulation. NAC is supportive but less consistent, and most benefits take roughly three months to appear. The key practical point is to use the 40:1 myo-inositol-to-D-chiro-inositol ratio from the positive trials and, if pregnancy is the goal, treat these as a complement to ovulation-induction care rather than a fertility treatment in their own right.

Polycystic ovary syndrome (PCOS) sits at the intersection of insulin resistance, mild chronic inflammation, and disordered ovulation, which is why a few supplements with metabolic effects have become standard adjuncts. This stack — inositol, vitamin D, NAC, and omega-3 — targets insulin sensitivity and the hormonal and lipid disturbances that follow. None replaces first-line care (lifestyle change, and metformin or combined oral contraceptives where indicated), and none is a fertility guarantee. But inositol in particular has enough randomized evidence that many clinicians now offer it routinely. Here is what each component does and the dose used in trials.

Inositol (Myo-Inositol), 2 g Twice Daily

Inositol is the best-supported component. Myo-inositol is a second messenger in insulin signaling, and in PCOS, randomized trials and reviews report that myo-inositol improves insulin sensitivity, lowers androgens, and restores more regular ovulation, with a side-effect profile far gentler than metformin. The most-studied regimen is myo-inositol 2 g twice daily (4 g/day), often combined with a small amount of D-chiro-inositol in the physiologic 40:1 ratio. Evidence quality varies and many trials are small, so frame inositol as a well-tolerated, reasonable first supplement that improves metabolic and reproductive markers — not a proven substitute for fertility treatment when pregnancy is the goal. Benefits typically take about three months.

Vitamin D, Repletion to Sufficiency (e.g. 2,000 IU/Day if Deficient)

Vitamin D deficiency is common in PCOS and tracks with worse insulin resistance. In a randomized controlled trial, vitamin D3 2,000 IU/day improved insulin measures (HOMA-IR), BMI, and lipid markers versus control, with the clearest benefit in women who were obese or insulin-resistant at baseline. The pattern across the literature is that correcting a real deficiency helps metabolic markers, while supplementing the already-replete does little. Check a 25(OH)D level and dose to sufficiency rather than guessing. Vitamin D is cheap, safe at sensible doses, and one of the higher-value moves if your level is low.

NAC (N-Acetylcysteine), 1.8 g Daily

N-acetylcysteine, a glutathione precursor and antioxidant, has been studied as an insulin sensitizer and ovulation aid in PCOS. A systematic review and meta-analysis of randomized trials found NAC improved ovulation and pregnancy rates compared with placebo, though it was generally less effective than metformin. Typical trial dosing is around 1.8 g/day. The evidence base is uneven and some individual studies are small or have been questioned, so the honest summary is "promising, supportive, not definitive". NAC is well tolerated (occasional GI upset) and a reasonable add-on, especially where antioxidant or ovulation support is the aim, but it should be discussed with the clinician managing fertility care.

Omega-3 (EPA/DHA), 1–2 g Daily

Omega-3 fatty acids target the lipid and inflammatory side of PCOS rather than ovulation. Trials and meta-analyses in PCOS report improvements in triglycerides and some insulin-resistance markers, with smaller and less consistent effects on androgens; the evidence is moderate and the magnitude modest. Frame omega-3 as cardiometabolic support — useful given the elevated long-term cardiovascular and metabolic risk in PCOS — not as a hormonal or fertility treatment. EPA/DHA 1–2 g/day is a sensible range, taken with food.

How to Run the Stack

Lifestyle remains the foundation: even modest weight loss improves ovulation and insulin sensitivity more reliably than any supplement, and PCOS should be diagnosed and managed with a clinician rather than self-treated. A reasonable evidence-led order is myo-inositol 4 g/day (split dosing) as the core, vitamin D repletion if your 25(OH)D is low, and then NAC ~1.8 g/day and omega-3 1–2 g/day depending on whether ovulation support or lipid/inflammatory support is the priority. The 40:1 myo-inositol to D-chiro-inositol ratio used in most positive trials matters — choose a product that states it rather than a D-chiro-heavy blend, which performed worse at higher doses. Give it about three months and track menstrual regularity and relevant labs. If pregnancy is the goal, coordinate with your fertility team — these supplements complement, but do not replace, ovulation-induction protocols. Avoid high-dose combinations without medical input, and review interactions if you also take metformin or a combined oral contraceptive.

Sources

  1. Kamenov Z, Gateva A. "Inositols in PCOS." Molecules, 2020;25(23):5566. PMID: 33260918. DOI: 10.3390/molecules25235566.
  2. Thakker D, Raval A, Patel I, Walia R. "N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials." Obstetrics and Gynecology International, 2015;2015:817849. PMID: 25653680. DOI: 10.1155/2015/817849.
  3. Wen X, Wang L, Li F, Yu X. "Effects of vitamin D supplementation on metabolic parameters in women with polycystic ovary syndrome: a randomized controlled trial." Journal of Ovarian Research, 2024;17(1):147. PMID: 39014475. DOI: 10.1186/s13048-024-01473-6.
  4. Ye J, Cen S, Qi Q, et al. "Effectiveness of mineral supplements (magnesium, chromium, zinc, selenium, chromium picolinate) in reducing insulin resistance in polycystic ovary syndrome: a meta-analysis of randomized controlled trials." BMC Endocrine Disorders, 2026;26(1). PMID: 41580698. DOI: 10.1186/s12902-025-02158-x.